| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2644345A1 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
| 09/20/2007 | CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | CA2643267A1 N-formyl hydroxylamine compounds |
| 09/20/2007 | CA2643222A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | CA2643066A1 Pyrazole compounds |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1833824A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 09/19/2007 | EP1833822A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/19/2007 | EP1833817A2 Synthesis of ccr5 receptor antagonists |
| 09/19/2007 | EP1833816A1 Substituted piperidines as renin inhibitors |
| 09/19/2007 | EP1833815A2 A process for preparation of imatinib base |
| 09/19/2007 | EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns) |
| 09/19/2007 | EP1833795A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 09/19/2007 | EP1833794A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 09/19/2007 | EP1833792A1 Substituted piperidine compounds for use as ccr5 modulators |
| 09/19/2007 | EP1833481A1 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 09/19/2007 | EP1833480A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 09/19/2007 | EP1740544B1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 09/19/2007 | EP1664025B1 Pyrrol derivatives with antibacterial activity |
| 09/19/2007 | EP1585734A4 Anti-inflammatory medicaments |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 09/19/2007 | CN101039938A Diphenyl substituted alkanes as flap inhibitors |
| 09/19/2007 | CN101039937A Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors |
| 09/19/2007 | CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 09/19/2007 | CN101039931A Novel product, method and intermediates for the preparation of azetidine derivatives |
| 09/19/2007 | CN101039930A 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 09/19/2007 | CN101039929A Novel anthranilamides useful for controlling invertebrate pests |
| 09/19/2007 | CN101039920A 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 09/19/2007 | CN101039918A Small molecule modulators of cytokine activity |
| 09/19/2007 | CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers |
| 09/19/2007 | CN101039912A Pyridine derivatives and the preparation and the therapeutic use thereof |
| 09/19/2007 | CN101039911A Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 09/19/2007 | CN101039907A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 09/19/2007 | CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101039900A 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101039718A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 09/19/2007 | CN101036648A Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 09/19/2007 | CN100338058C 新的吲哚衍生物 The new indole derivatives |
| 09/19/2007 | CN100338057C Halogenated nitrobutadienes for controlling animal pests |
| 09/19/2007 | CN100338050C Amine acid salt compounds and process for the production thereof |
| 09/19/2007 | CN100338047C Process for the preparation of pyrazolopyrimidin ones |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100338041C Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/19/2007 | CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/19/2007 | CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271265 Cyanine compounds and their application as quenching compounds |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271260 3,4-dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271191 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |
| 09/18/2007 | US7271182 Salts of benzimidazole compound and use thereof |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271175 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 09/18/2007 | US7271174 Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/16/2007 | CA2581960A1 Iap bir domain binding compounds |
| 09/13/2007 | WO2007104034A2 Glucokinase activators |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/13/2007 | WO2007103554A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | WO2007103260A1 Phosphodiesterase 10 inhibitors |
| 09/13/2007 | WO2007102771A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
| 09/13/2007 | WO2007102768A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them . |
| 09/13/2007 | WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102594A1 Polymer complex |
| 09/13/2007 | WO2007102069A1 Improved prodrugs of cc-1065 analogs |
| 09/13/2007 | WO2007102059A1 Sulfonyl benzimidazole derivatives |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007087026A3 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 09/13/2007 | WO2007071055A8 Compositions and methods for modulating gated ion channels |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213373 Indazole derivatives as CRF antagonists |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists |
| 09/13/2007 | US20070213345 Immuno Inhibitory Pyrazolone Compounds |
| 09/13/2007 | US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213339 Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions |
| 09/13/2007 | US20070213338 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |